Pulse Biosciences, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year One
Pulse Biosciences, Inc. (PLSE) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $558.00 thousand as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-02-19
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $558.00K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $575.00K.
- 2025-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $575.00K.
- 2025-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $555.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2025-12-31 | $558.00K 10-K · filed 2026-02-19 |
| 2025-09-30 | $575.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $575.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $555.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $665.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $665.00K 10-Q · filed 2024-10-30 |
| 2024-06-30 | $665.00K 10-Q · filed 2024-08-19 |
| 2024-03-31 | $665.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $665.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $665.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $665.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $665.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $665.00K 10-K · filed 2023-03-31 |
| 2022-09-30 | $665.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $665.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $665.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $665.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $665.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $665.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $665.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $665.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | $665.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $665.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $665.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $665.00K 10-K · filed 2020-03-16 |
| 2019-09-30 | $665.00K 10-Q · filed 2019-11-07 |
| 2019-06-30 | $665.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $665.00K 10-Q · filed 2019-05-03 |
| 2018-12-31 | $665.00K 10-K · filed 2019-03-14 |
| 2018-09-30 | $665.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $665.00K 10-Q · filed 2018-07-31 |
| 2018-03-31 | $665.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $665.00K 10-K · filed 2018-03-16 |
| 2016-12-31 | $665.00K 10-K · filed 2017-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |